Results Male MDD patients (33.1%) were rather inpatients, suffered from moderate to high suicidality levels, received noradrenergic and specific serotonergic antidepressants (ADs) as first‐line AD treatment, generally higher mean AD daily doses, and showed a trend towards a more frequent administration of add‐on treatments.
← all excerpts
Sex-related effects in major depressive disorder: Results of the European Group for the Study of Resistant Depression.
1
—
—